The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era
JAMA · 02.06.2026 · 335 (21) · 1841
DOI: 10.1001/jama.2026.5537 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 02.06.2026. Verfasst von Daniel E Lieberman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harvard University, Cambridge, Massachusetts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
This Perspective describes the challenges of prescribing exercise for weight loss, with and without the use of glucagon-like peptide 1 (GLP-1) receptor agonists, and discusses strategies clinicians can use to improve adherence to exercise recommendations.
Autor:innen und Institutionen
- Harvard University, Cambridge, Massachusetts.
- Pennington Biomedical Research Center, Baton Rouge, Louisiana.
Zitieren
APA
Lieberman, D. E., Aslan, D. H., & Heymsfield, S. B. (2026). The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era. JAMA, 335(21), 1841. https://doi.org/10.1001/jama.2026.5537
Vancouver
Lieberman DE, Aslan DH, Heymsfield SB. The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era. JAMA. 2026;335(21):1841. doi:10.1001/jama.2026.5537
BibTeX
@article{Lieberman2026,
author = {Lieberman, Daniel E and Aslan, Daniel H and Heymsfield, Steven B},
title = {The Conundrum of Exercise for Weight Management in the GLP-1 Receptor Agonist Era},
journal = {JAMA},
year = {2026},
volume = {335},
number = {21},
pages = {1841},
doi = {10.1001/jama.2026.5537}
}
EUVIMED